Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results
Go back to Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results| (NASDAQ: NAGE) | Delayed: 2.49 -0.09 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.58 | 52 Week High | $ | |||
| Open | $2.58 | 52 Week Low | $ | |||
| Day High | $2.59 | P/E | N/A | |||
| Day Low | $2.46 | EPS | $ | |||
| Volume | 555,763 | |||||



